News

Morphotek announced that FDA has cleared its investigational new drug (IND) application to study MORAb-004, for the treatment of patients with solid tumors. MORAb-004 targets endosialin, a protein

Roche has announced that it will start phase III clinical investigations for aleglitazar, its innovative PPAR co-agonist R1439 which is uniquely designed to reduce cardiovascular morbidity and mortality

MDS Pharma has announced that renovation and expansion of its discovery pharmacology operation in Taiwan is under way, to serve the growing global demand for work performed in

GlaxoSmithKline has announced that it has entered into an agreement to form a new joint venture with Shenzhen Neptunus Interlong. The latter is focused on developing and manufacturing

Pharmasset has announced the completion of the single ascending dose study, and has begun dosing in a multiple ascending dose trial with PSI-7851. Its a nucleotide analog polymerase

“Today’s announcement marks another milestone in the successful partnership between ICON and Lilly,” commented Peter Gray, CEO at ICON. “We have worked together to create a truly flexible

DOR has announced that it has received Protocol Assistance feedback from the European Medicines Agency (EMEA) on the design of its confirmatory, pivotal, Phase-III clinical trial. The trial

Abbott has launched the EAS Myoplex Strength Formula nutrition shake, designed to help sportsmen and fitness seekers refuel after physical activity. The ready-to-drink sports nutrition shake comes in

BioLife Solutions has announced the completion of construction and validation of its internal GMP manufacturing facility. The company has released first production lot of its biopreservation media products